1AOX - JenaLib

Asym./Biol. Unit - manually (Jmol Viewer)

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   I DOMAIN FROM INTEGRIN ALPHA2-BETA1

Authors :   J. Emsley, S. L. King, J. M. Bergelson, R. C. Liddington

Date :   13 Jul 97 (Deposition) - 25 Nov 98 (Release) - 24 Feb 09 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.10

Chains :   Asym./Biol. Unit : A,B

Keywords :   Integrin, Cell Adhesion, Glycoprotein (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   J. Emsley, S. L. King, J. M. Bergelson, R. C. Liddington
Crystal Structure Of The I Domain From Integrin Alpha2Beta1.
J. Biol. Chem. V. 272 28512 1997
PubMed-ID: 9353312 | Reference-DOI: 10.1074/JBC.272.45.28512
(for further references see the PDB file header)

Molecule 1 - INTEGRIN ALPHA 2 BETA
	Chains	:	A, B
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI BL21
	Expression System Plasmid	:	PGEX-KT
	Expression System Strain	:	BL21
	Expression System Taxid	:	511693
	Expression System Vector Type	:	PLASMID
	Fragment	:	I DOMAIN
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606

		1	2
Asymmetric/Biological Unit	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (1, 2)

No.	Name	Count	Type	Full Name
1	MG	2	Ligand/Ion	MAGNESIUM ION

Asymmetric Unit (4, 4)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	SER A:153 , SER A:155 , ASP A:254 , HOH A:699 , HOH A:700 , HOH A:701	BINDING SITE FOR RESIDUE MG A 400
2	AC2	SOFTWARE	SER B:153 , SER B:155 , ASP B:254 , HOH B:693 , HOH B:695 , HOH B:696	BINDING SITE FOR RESIDUE MG B 401
3	MGA	UNKNOWN	ASP A:151 , SER A:153 , SER A:155 , THR A:221 , ASP A:254	MG BINDING SITE.
4	MGB	UNKNOWN	ASP B:151 , SER B:153 , SER B:155 , THR B:221 , ASP B:254	MG BINDING SITE.

Asymmetric/Biological Unit

No.	Residues
1	A:140	-	B:140

Asymmetric/Biological Unit

No.	Residues
1	Tyr A:157	-	Pro A:158
2	Ile A:306	-	Pro A:307
3	Tyr B:157	-	Pro B:158

(no "SAP(SNP)/Variant" information available for 1AOX)

Asymmetric/Biological Unit (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	FG_GAP	PS51470	FG-GAP repeat profile.	ITA2_HUMAN	34-92 101-161 366-420 477-539 423-475 540-598 602-664	2	- - A:337-339 B:337-337 - - - -
2	VWFA	PS50234	VWFA domain profile.	ITA2_HUMAN	174-361	2	A:145-332 B:145-332

Asymmetric/Biological Unit (7, 13)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000296585	1a	ENSE00002047974	chr5:52285156-52285362	207	ITA2_HUMAN	1-22	22	0	-	-
1.2	ENST00000296585	2	ENSE00001082059	chr5:52322578-52322698	121	ITA2_HUMAN	22-62	41	0	-	-
1.3	ENST00000296585	3	ENSE00001082086	chr5:52337942-52338051	110	ITA2_HUMAN	62-99	38	0	-	-
1.4	ENST00000296585	4	ENSE00001082085	chr5:52340831-52340922	92	ITA2_HUMAN	99-129	31	0	-	-
1.5	ENST00000296585	5	ENSE00001082071	chr5:52344193-52344307	115	ITA2_HUMAN	130-168	39	2	A:139-139 B:137-139	1 3
1.6	ENST00000296585	6	ENSE00001082076	chr5:52344473-52344600	128	ITA2_HUMAN	168-210	43	2	A:139-181 B:139-181	43 43
1.7	ENST00000296585	7	ENSE00001082063	chr5:52347241-52347389	149	ITA2_HUMAN	211-260	50	2	A:182-231 B:182-231	50 50
1.8	ENST00000296585	8	ENSE00001082075	chr5:52351368-52351518	151	ITA2_HUMAN	260-310	51	2	A:231-281 B:231-281	51 51
1.9	ENST00000296585	9	ENSE00001082081	chr5:52351814-52351979	166	ITA2_HUMAN	311-366	56	2	A:282-337 B:282-337	56 56
1.10	ENST00000296585	10	ENSE00001082065	chr5:52353855-52353931	77	ITA2_HUMAN	366-391	26	2	A:337-337 B:337-337	1 1
1.11	ENST00000296585	11	ENSE00001082067	chr5:52355704-52355842	139	ITA2_HUMAN	392-438	47	1	A:338-339 -	2 -
1.12	ENST00000296585	12	ENSE00001082084	chr5:52356731-52356876	146	ITA2_HUMAN	438-486	49	0	-	-
1.13	ENST00000296585	13	ENSE00001082064	chr5:52358616-52358759	144	ITA2_HUMAN	487-534	48	0	-	-
1.14	ENST00000296585	14	ENSE00001082077	chr5:52360742-52360945	204	ITA2_HUMAN	535-602	68	0	-	-
1.15b	ENST00000296585	15b	ENSE00001082062	chr5:52361671-52361807	137	ITA2_HUMAN	603-648	46	0	-	-
1.16	ENST00000296585	16	ENSE00001082058	chr5:52362948-52363087	140	ITA2_HUMAN	648-695	48	0	-	-
1.17	ENST00000296585	17	ENSE00001082055	chr5:52365939-52366090	152	ITA2_HUMAN	695-745	51	0	-	-
1.18	ENST00000296585	18	ENSE00001082082	chr5:52367768-52367878	111	ITA2_HUMAN	746-782	37	0	-	-
1.19	ENST00000296585	19	ENSE00001082060	chr5:52368443-52368525	83	ITA2_HUMAN	783-810	28	0	-	-
1.20	ENST00000296585	20	ENSE00001082054	chr5:52368948-52369089	142	ITA2_HUMAN	810-857	48	0	-	-
1.21	ENST00000296585	21	ENSE00001082080	chr5:52370215-52370307	93	ITA2_HUMAN	858-888	31	0	-	-
1.22	ENST00000296585	22	ENSE00001082083	chr5:52370891-52370967	77	ITA2_HUMAN	889-914	26	0	-	-
1.23	ENST00000296585	23	ENSE00001082056	chr5:52371051-52371134	84	ITA2_HUMAN	914-942	29	0	-	-
1.24	ENST00000296585	24	ENSE00001082070	chr5:52374602-52374704	103	ITA2_HUMAN	942-976	35	0	-	-
1.25	ENST00000296585	25	ENSE00001082068	chr5:52376341-52376451	111	ITA2_HUMAN	977-1013	37	0	-	-
1.26	ENST00000296585	26	ENSE00001082079	chr5:52377422-52377526	105	ITA2_HUMAN	1014-1048	35	0	-	-
1.27	ENST00000296585	27	ENSE00001082061	chr5:52379170-52379283	114	ITA2_HUMAN	1049-1086	38	0	-	-
1.28	ENST00000296585	28	ENSE00001082057	chr5:52382782-52382871	90	ITA2_HUMAN	1087-1116	30	0	-	-
1.29	ENST00000296585	29	ENSE00001082066	chr5:52385776-52385892	117	ITA2_HUMAN	1117-1155	39	0	-	-
1.30e	ENST00000296585	30e	ENSE00001262757	chr5:52386349-52390609	4261	ITA2_HUMAN	1156-1181	26	0	-	-

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:201
 aligned with ITA2_HUMAN | P17301 from UniProtKB/Swiss-Prot  Length:1181

    Alignment length:240
                                   177       187       197       207       217       227       237       247       257       267       277       287       297       307       317       327       337       347       357       367       377       387       397       407
           ITA2_HUMAN   168 PCPSLIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKTKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSMLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALLEKAGTLGEQIFSIEGTVQGGDNFQMEMSQVGFSADYSSQNDILMLGAVGAFGWSGT 407
               SCOP domains d1aoxa_ A: Integrin alpha2-beta1                                                                                                                                                                                                                 SCOP domains
               CATH domains 1aoxA00 A:139-339  [code=3.40.50.410, no name defined]                                                                                                                                                                                           CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....eeeeeeee.......hhhhhhhhhhhhhh.......eeeeeeee...eeeee.......hhhhhhhhhh..........hhhhhhhhhhh...hhh......eeeeeeee......hhhhhhhhhhhhh..eeeeeeee.hhhhh.....hhhhhhhh......hhhheeee..hhhhhhhhhhhhhhhh....---------------------------------------.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ------VWFA  PDB: A:145-332 UniProt: 174-361                                                                                                                                                       ----FG_GAP  PDB: A:337-339 UniProt: 366-420    PROSITE
           Transcript 1 (1) 1------------------------------------------Exon 1.7  PDB: A:182-231 UniProt: 211-260         ---------------------------------------------------------------------------------------------------------Exon 1.10  PDB: A:337-337 Exon 1.11        Transcript 1 (1)
           Transcript 1 (2) Exon 1.6  PDB: A:139-181 UniProt: 168-210  -------------------------------------------------Exon 1.8  PDB: A:231-281 UniProt: 260-310          Exon 1.9  PDB: A:282-337 UniProt: 311-366               ----------------------------------------- Transcript 1 (2)
                 1aox A 139 SCPSLIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKTKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSMLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALLEKAGTLGEQIFSIEG---------------------------------------GT 339
                                   148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328        |-         -         -         -       339
                                                                                                                                                                                                                                337                                     338

Chain B from PDB  Type:PROTEIN  Length:201
 aligned with ITA2_HUMAN | P17301 from UniProtKB/Swiss-Prot  Length:1181

    Alignment length:201
                                   175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365 
           ITA2_HUMAN   166 TQPCPSLIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKTKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSMLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALLEKAGTLGEQIFSIEG 366
               SCOP domains d1aoxb_ B: Integrin alpha2-beta1                                                                                                                                                                          SCOP domains
               CATH domains 1aoxB00 B:137-337  [code=3.40.50.410, no name defined]                                                                                                                                                    CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......eeeeeeee.......hhhhhhhhhhhhhh........eeeeeee...eeeee.......hhhhhhhhhh..........hhhhhhhhhhh...hhh......eeeeeeee......hhhhhhhhhhhhh..eeeeeeee..hhhhh....hhhhhhhhhh....hhhheeee..hhhhhhhhhhhhhhhh.... Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE --------VWFA  PDB: B:145-332 UniProt: 174-361                                                                                                                                                       ----F PROSITE
           Transcript 1 (1) 1.5------------------------------------------Exon 1.7  PDB: B:182-231 UniProt: 211-260         ---------------------------------------------------------------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) --Exon 1.6  PDB: B:139-181 UniProt: 168-210  -------------------------------------------------Exon 1.8  PDB: B:231-281 UniProt: 260-310          Exon 1.9  PDB: B:282-337 UniProt: 311-366                Transcript 1 (2)
                 1aox B 137 RSSCPSLIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKTKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSMLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALLEKAGTLGEQIFSIEG 337
                                   146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a/b) (23833)

Fold: vWA-like (111)

Superfamily: vWA-like (111)

Family: Integrin A (or I) domain (84)

Protein domain: Integrin alpha2-beta1 (3)

Human (Homo sapiens) [TaxId: 9606] (3)

1a	d1aoxa_	A:
1b	d1aoxb_	B:

Asymmetric/Biological Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 3-Layer(aba) Sandwich (12045)

Topology: Rossmann fold (7312)

Homologous Superfamily: [code=3.40.50.410, no name defined] (87)

Human (Homo sapiens) (66)

1a	1aoxA00	A:139-339
1b	1aoxB00	B:137-337

(no "Pfam Domain" information available for 1AOX)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B (ITA2_HUMAN | P17301)

molecular function
	GO:0005518	collagen binding	Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
	GO:0098639	collagen binding involved in cell-matrix adhesion	Any collagen binding that occurs as part of cell-matrix adhesion.
	GO:0038064	collagen receptor activity	Combining with a collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0005178	integrin binding	Interacting selectively and non-covalently with an integrin.
	GO:0043236	laminin binding	Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0032403	protein complex binding	Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0046982	protein heterodimerization activity	Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
	GO:0001618	virus receptor activity	Combining with a virus component and mediating entry of the virus into the cell.
biological process
	GO:0009887	animal organ morphogenesis	Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0033627	cell adhesion mediated by integrin	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.
	GO:0008283	cell proliferation	The multiplication or reproduction of cells, resulting in the expansion of a cell population.
	GO:0007160	cell-matrix adhesion	The binding of a cell to the extracellular matrix via adhesion molecules.
	GO:0031589	cell-substrate adhesion	The attachment of a cell to the underlying substrate via adhesion molecules.
	GO:0071392	cellular response to estradiol stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
	GO:0071260	cellular response to mechanical stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0071407	cellular response to organic cyclic compound	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0038065	collagen-activated signaling pathway	A series of molecular signals initiated by collagen binding to a cell surface receptor, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal.
	GO:0045184	establishment of protein localization	The directed movement of a protein to a specific location.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0007565	female pregnancy	The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
	GO:0048041	focal adhesion assembly	The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity.
	GO:0070365	hepatocyte differentiation	The process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte. A hepatocyte is specialized epithelial cell that is organized into interconnected plates called lobules, and is the main structural component of the liver.
	GO:0006971	hypotonic response	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hypotonic environment, i.e. an environment with a lower concentration of solutes than the organism or cell.
	GO:0007229	integrin-mediated signaling pathway	A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0030879	mammary gland development	The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
	GO:0048333	mesodermal cell differentiation	The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
	GO:0043388	positive regulation of DNA binding	Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
	GO:0010694	positive regulation of alkaline phosphatase activity	Any process that increases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
	GO:0045785	positive regulation of cell adhesion	Any process that activates or increases the frequency, rate or extent of cell adhesion.
	GO:0031346	positive regulation of cell projection organization	Any process that activates or increases the frequency, rate or extent of the process involved in the formation, arrangement of constituent parts, or disassembly of cell projections.
	GO:0033343	positive regulation of collagen binding	Any process that activates or increases the frequency, rate or extent of collagen binding.
	GO:0032967	positive regulation of collagen biosynthetic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
	GO:0010634	positive regulation of epithelial cell migration	Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
	GO:0050729	positive regulation of inflammatory response	Any process that activates or increases the frequency, rate or extent of the inflammatory response.
	GO:0002687	positive regulation of leukocyte migration	Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
	GO:0060100	positive regulation of phagocytosis, engulfment	Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
	GO:0050927	positive regulation of positive chemotaxis	Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
	GO:0014911	positive regulation of smooth muscle cell migration	Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
	GO:0048661	positive regulation of smooth muscle cell proliferation	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
	GO:0045987	positive regulation of smooth muscle contraction	Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.
	GO:0045727	positive regulation of translation	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
	GO:0051971	positive regulation of transmission of nerve impulse	Any process that activates, maintains or increases the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation.
	GO:0033591	response to L-ascorbic acid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus.
	GO:0014075	response to amine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amine stimulus. An amine is a compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0001666	response to hypoxia	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
	GO:0014850	response to muscle activity	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus.
	GO:0014070	response to organic cyclic compound	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0071107	response to parathyroid hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus.
	GO:0043589	skin morphogenesis	The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner, sensitive and vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
	GO:0006929	substrate-dependent cell migration	The orderly movement of a cell from one site to another along a substrate such as the extracellular matrix; the migrating cell forms a protrusion that attaches to the substrate.
	GO:0046718	viral entry into host cell	The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
	GO:0042060	wound healing	The series of events that restore integrity to a damaged tissue, following an injury.
cellular component
	GO:0030424	axon	The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
	GO:0043679	axon terminus	Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal button is a specialized region of it.
	GO:0045178	basal part of cell	The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
	GO:0042995	cell projection	A prolongation or process extending from a cell, e.g. a flagellum or axon.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0005925	focal adhesion	Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0034666	integrin alpha2-beta1 complex	An integrin complex that comprises one alpha2 subunit and one beta1 subunit.
	GO:0008305	integrin complex	A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0048471	perinuclear region of cytoplasm	Cytoplasm situated near, or occurring around, the nucleus.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		MG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		MGA	[ RasMol ]	+environment [ RasMol ]
		MGB	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Ile A:306 - Pro A:307	[ RasMol ]
		Tyr A:157 - Pro A:158	[ RasMol ]
		Tyr B:157 - Pro B:158	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1aox
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ITA2_HUMAN \| P17301
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ITA2_HUMAN \| P17301
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	ITA2_HUMAN \| P17301	:	1dzi 1pqb 1v7p 4bj3 5hj2

(no "Related Entries Specified in the PDB File" available for 1AOX)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 2)

Sites (4, 4)

SS Bonds (1, 1)

Cis Peptide Bonds (3, 3)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (0, 0)

PROSITE Motifs (2, 4)

Exons (7, 13)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (1, 2)

Pfam Domains (0, 0)

Gene Ontology (73, 73)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File